Plasma levels of doxorubicin after IV bolus injection and infusion of the doxorubicin-DNA complex in rabbits and man. Comparison with free doxorubicin

Cancer Chemother Pharmacol. 1982;9(2):93-6. doi: 10.1007/BF00265386.

Abstract

When injected rapidly IV into rabbits, the plasma levels of free DOX decreased biphasically and the drug was distributed in a volume greater than the body volume. When given as a DNA complex, the area under the concentration versus time curve was increased 10-fold and the distribution volume reduced more than 100-fold. The DOX-DNA complex infused both in rabbits and in human patients reached steady state-concentrations 10 and 20 times higher, respectively, than free DOX infusion, and the distribution volumes were reduced accordingly. These results confirm that the observed lower cardiotoxicity of the DOX-DNA complex arises despite higher plasma concentrations of the drug.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • DNA / administration & dosage*
  • DNA / metabolism
  • DNA Adducts*
  • Doxorubicin / administration & dosage*
  • Doxorubicin / adverse effects
  • Doxorubicin / blood*
  • Doxorubicin / metabolism
  • Half-Life
  • Humans
  • Infusions, Parenteral
  • Injections, Intravenous
  • Kinetics
  • Rabbits

Substances

  • DNA Adducts
  • doxorubicin-DNA
  • Doxorubicin
  • DNA